These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22621609)

  • 1. Contrast-induced nephropathy: attributable incidence and potential harm.
    Pires de Freitas do Carmo L; Macedo E
    Crit Care; 2012 May; 16(3):127. PubMed ID: 22621609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study.
    Cely CM; Schein RM; Quartin AA
    Crit Care; 2012 Dec; 16(2):R67. PubMed ID: 22534554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis.
    Ehrmann S; Quartin A; Hobbs BP; Robert-Edan V; Cely C; Bell C; Lyons G; Pham T; Schein R; Geng Y; Lakhal K; Ng CS
    Intensive Care Med; 2017 Jun; 43(6):785-794. PubMed ID: 28197679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephropathy in critically Ill patients without preexisting renal disease.
    Polena S; Yang S; Alam R; Gricius J; Gupta JR; Badalova N; Chuang P; Gintautas J; Conetta R
    Proc West Pharmacol Soc; 2005; 48():134-5. PubMed ID: 16416679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bench-to-bedside review: preventive measures for contrast-induced nephropathy in critically ill patients.
    van den Berk G; Tonino S; de Fijter C; Smit W; Schultz MJ
    Crit Care; 2005 Aug; 9(4):361-70. PubMed ID: 16137385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting the incidence of contrast-induced nephropathy in patients undergoing computed tomography.
    Heras Benito M; Garrido Blázquez M; Gómez Sanz Y; Bernardez Mardomingo M; Ruiz Cacho J; Rodríguez Recio FJ; Fernández-Reyes Luis MJ
    Radiologia (Engl Ed); 2018; 60(4):326-331. PubMed ID: 29779857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing the risks and benefits of using emergency diagnostic radiocontrast studies to diagnose life-threatening illness in critically ill patients: a decision analysis.
    Ho KM
    Anaesth Intensive Care; 2016 Nov; 44(6):724-728. PubMed ID: 27832559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Background fluctuation of kidney function versus contrast-induced nephrotoxicity.
    Bruce RJ; Djamali A; Shinki K; Michel SJ; Fine JP; Pozniak MA
    AJR Am J Roentgenol; 2009 Mar; 192(3):711-8. PubMed ID: 19234268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
    Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
    J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the risk of contrast-induced nephropathy: a perspective on the controversies.
    Ellis JH; Cohan RH
    AJR Am J Roentgenol; 2009 Jun; 192(6):1544-9. PubMed ID: 19457817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotoxic Polypharmacy and Risk of Contrast Medium-Induced Nephropathy in Hospitalized Patients Undergoing Contrast-Enhanced CT.
    Ho YF; Hsieh KL; Kung FL; Wu FL; Hsieh LL; Chou H; Chen SJ
    AJR Am J Roentgenol; 2015 Oct; 205(4):703-8. PubMed ID: 26397318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylcysteine in critically ill patients undergoing contrast-enhanced computed tomography: a randomized trial.
    Burns KE; Priestap F; Martin C
    Clin Nephrol; 2010 Oct; 74(4):323-6. PubMed ID: 20875388
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictive value of the RIFLE urine output criteria on contrast-induced nephropathy in critically ill patients.
    Hocine A; Defrance P; Lalmand J; Delcour C; Biston P; Piagnerelli M
    BMC Nephrol; 2016 Mar; 17():36. PubMed ID: 27021438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-induced nephropathy in the critically-ill patient: focus on emergency screening and prevention.
    Lameire N
    Acta Clin Belg; 2007; 62 Suppl 2():346-52. PubMed ID: 18283997
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous Contrast: Friend or Foe? A Review on Contrast-Induced Nephropathy.
    Do C
    Adv Chronic Kidney Dis; 2017 May; 24(3):147-149. PubMed ID: 28501076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-induced nephropathy: nursing implications.
    Isaac S
    Crit Care Nurse; 2012 Jun; 32(3):41-8. PubMed ID: 22661157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-induced nephropathy: pathophysiology and preventive strategies.
    Jorgensen AL
    Crit Care Nurse; 2013 Feb; 33(1):37-46. PubMed ID: 23377156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.
    Chousterman BG; Bouadma L; Moutereau S; Loric S; Alvarez-Gonzalez A; Mekontso-Dessap A; Laissy JP; Rahmouni A; Katsahian S; Brochard L; Schortgen F
    J Crit Care; 2013 Oct; 28(5):701-9. PubMed ID: 23683568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
    Feldkamp T; Baumgart D; Elsner M; Herget-Rosenthal S; Pietruck F; Erbel R; Philipp T; Kribben A
    Clin Nephrol; 2006 Nov; 66(5):322-30. PubMed ID: 17140161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast media induced nephropathy: a literature review of the available evidence and recommendations for practice.
    Deek H; Newton P; Sheerin N; Noureddine S; Davidson PM
    Aust Crit Care; 2014 Nov; 27(4):166-71. PubMed ID: 24461960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.